Abstract
Objective : In the past 8 years, 120 cases of hematological disorders were transplanted from the HLA identical donors.Method: Using chemotherapy based conditioning regimen with cyclophosphamide 200 mg/kg and busulfan 15–16 mg/kg, 80 cases of β-thalassemia major and 35 cases of leukemia and five patients with aplastic anemia had received bone marrow transplantation.Result : The five-year-survival in thalassemic group was 72%, for leukemic group (acute and chronic) was 58%, and also for aplastic anemia 65%. Transplantation related mortality was the cause of death in 29 cases. The two major causes of death were acute graft versus host disease and poor medical condition of patients before marrow transplantation.Conclusion : At the present time, allogenic marrow transplantation is curative mode of treatment for many hematological diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Clinical bone marrow and blood stem cell transplantation, Kerry atkinson, second edn. 2000.
Santos GW, Tutschka PJ, Brookmeyer Ret al. Marrow transplantation for acute none-lymphocytic leukemia after treatment with busulfan and cyclophosphamide.New Eng J Med 1983; 309: 1347–1353.
Lucarrelli G, Clift RA, Galimberti M, Polchi Polchi Pet al. Marrow transplantation for pateints with thalassemia. Results in class III pateints.Blood 1996; 87: 2082–2088.
Thomas ED, Storb R, Clift RA,et al. Bone marrow transplantation.New Eng J Med (1975); 292: 832–902.
Tyndall A, Gratwohl A. Hematopoitic stem cell progenitor cells in the treatment of severe autoimmune disease.Ann Rheumatic Dis 1997; 55: 149–151.
Tutschka PJ, Copelan EA, Klein J. Bone marrow transplantation for leukemia following anew busulfan and cyclophosphamide regimen.Blood 1987; 70: 1382–1388.
Haire WD, Ruuby EJ, Gordon BGet al. Multiple organ dysfunrion in bone marrow transplantation.J Am Med Assoc 1995; 274: 1285–1295.
Borrin, MM, Bach FH, Van Bekkum DWet al. 25th aniversary of the first successful allogenic marrow transplantation.Bone Marrow Trans 1994; 14: 211–212.
Thomas ED, Storb R, Clift RAet al. Bone marrow transplantation.N Eng J Med 1975; 292: 832–902.
Thomas ED. Marrow Transplantation for acute nonelymphocytic leukemia in first remission.N Eng J Med 1983; 309: 1539.
Olivieri NF, Brittenham GM. Iron chelation therapy and the treatment of thalassemia.Blood 1997; 89: 739–761.
Clift RA, Hohnson FL. Marrow transplantaion for thalassemia U.S.A. experieces.B Marr Trans 1997; 19: 57–59.
Nourani Khojasteh H, Zakernia M, Ramzi M, Haghshenas M. Acute graft versus host disease with low dose antithymocyte globulin in thalassemic marrow transplantation.East Mediter Health J 1999; 5(3).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khojasteh, N.H., Zakernia, M., Ramzi, M. et al. Bone marrow transplantation for hematological disorders—Shiraz experience. Indian J Pediatr 69, 31–32 (2002). https://doi.org/10.1007/BF02723773
Issue Date:
DOI: https://doi.org/10.1007/BF02723773